The carcinogenic metabolite acetaldehyde impairs cGAS activity to negatively regulate antiviral and antitumor immunity
Cancer Letters · 2025
DOI: 10.1016/j.canlet.2025.217615 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Xiao-Yue Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Medical Research Institute, Zhongnan Hospital of Wuhan University, Frontier Science Center for Immunology, State K…. Hauptthemen laut MEDLINE: Acetaldehyde, Nucleotidyltransferases, Colorectal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben.
Abstract (Originalsprache)
The cGAS-MITA/STING pathway plays critical roles in both host defense against DNA virus and intrinsic antitumor immunity by sensing viral genomic DNA or dis-located mitochondrial/cellular DNA. Whether carcinogenic metabolites can target the cGAS-MITA axis to promote tumorigenesis is unknown. In this study, we identified acetaldehyde, a carcinogenic metabolite, as a suppressor of the cGAS-MITA pathway. Acetaldehyde inhibits the DNA virus herpes simplex virus 1 (HSV-1)- and transfected DNA-triggered but not cGAMP-induced activation of downstream components and induction of downstream effector genes. Mechanistically, acetaldehyde impairs the binding of cGAS to DNA as well as the phase separation of the cGAS-DNA complex in cells. In mouse models, acetaldehyde inhibits antiviral cytokine production, promotes viral replication and lethality upon HSV-1 infection. In a colorectal tumor xenograft model, acetaldehyde promotes tumor growth and inhibits CD8+ T cell infiltration by targeting cGAS in both the tumor cells and immune cells in mice. Bioinformatic analysis indicates that expression of acetaldehyde dehydrogenase 2 (ALDH2), which converts acetaldehyde to acetic acid, is negatively correlated with stimulatory immune signatures in clinical colorectal tumors, and higher ALDH2 expression exhibits better prognosis of colorectal cancer patients. Collectively, our results suggest that acetaldehyde impairs cGAS activity to inhibit the cGAS-MITA axis, which contributes to its effects on carcinogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Medical Research Institute, Zhongnan Hospital of Wuhan University, Frontier Science Center for Immunology, State Key Laboratory of Virology, Wuhan University, Wuhan, Hubei, China.
- Department of Infectious Diseases, Medical Research Institute, Zhongnan Hospital of Wuhan University, Frontier Science Center for Immunology, State Key Laboratory of Virology, Wuhan University, Wuhan, Hubei, China. Elec…
Zitieren
APA
Zhou, X. Y., Zhang, N. C., Zhang, X. N., Sun, X. D., Ruan, Z. L., Yang, Q., Hu, M. M., & Shu, H. B. (2025). The carcinogenic metabolite acetaldehyde impairs cGAS activity to negatively regulate antiviral and antitumor immunity. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217615
Vancouver
Zhou XY, Zhang NC, Zhang XN, Sun XD, Ruan ZL, Yang Q, et al. The carcinogenic metabolite acetaldehyde impairs cGAS activity to negatively regulate antiviral and antitumor immunity. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217615
BibTeX
@article{Zhou2025,
author = {Zhou, Xiao-Yue and Zhang, Nian-Chao and Zhang, Xia-Nan and Sun, Xue-Dan and Ruan, Zi-Lun and Yang, Qing and Hu, Ming-Ming and Shu, Hong-Bing},
title = {The carcinogenic metabolite acetaldehyde impairs cGAS activity to negatively regulate antiviral and antitumor immunity},
journal = {Cancer Letters},
year = {2025},
doi = {10.1016/j.canlet.2025.217615}
}
EUVIMED